Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
3D bioprinting for drug discovery and development in pharmaceutics
Weijie Peng
, Pallab Datta
, Bugra Ayan
, Veli Ozbolat
, Donna Sosnoski
,
Ibrahim T. Ozbolat
Engineering Science and Mechanics
Department of Neurosurgery
Penn State Cancer Institute
Cancer Institute, Mechanisms of Carcinogenesis
Center for Neural Engineering
Research output
:
Contribution to journal
›
Review article
›
peer-review
285
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of '3D bioprinting for drug discovery and development in pharmaceutics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bioprinting
100%
Drug Development
100%
Drug Discovery
100%
Pharmaceutics
100%
3D Bioprinting
100%
Three-dimensional Modeling
42%
Pharmaceutical Study
42%
Three-dimensional Tissue Model
42%
Fabrication Methods
28%
Two Dimensional Model
28%
In Vitro-in Vivo Correlation (IVIVC)
28%
Pharmaceutical Development
28%
Drug Delivery
14%
Clinical Trials
14%
Recent Advances
14%
Full Potential
14%
Bioink
14%
Comparative Analysis
14%
Financial Resources
14%
Extrusion
14%
Decision Basis
14%
High-throughput Screening
14%
Informed Decision-making
14%
Catastrophic Failure
14%
Regenerative Medicine
14%
Tissue Engineering
14%
Analysis of Similarity (ANOSIM)
14%
Commercial Drugs
14%
Drug Screening
14%
Animal Testing
14%
Difference Analysis
14%
Toxicology
14%
Time Resources
14%
Native Tissue
14%
Comparative Literature
14%
Development Cycle
14%
Living Tissue
14%
Tissue Architecture
14%
Drug pipeline
14%
Tissue Constructs
14%
Drug Discovery Research
14%
Chemical Attributes
14%
Limited Availability
14%
Heterogeneous Composition
14%
Toxicological Testing
14%
Efficacy Testing
14%
Spatial Attributes
14%
Screening Drugs
14%
Efficacy Prediction
14%
Regenerative Tissue
14%
Droplet-based Bioprinting
14%
Tissue Biofabrication
14%
Reliable Prediction
14%
Computational Advances
14%
Tissue Model
14%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
100%
Drug Development
100%
Pharmaceutics
100%
Toxicology
50%
Clinical Trial
25%
High-Throughput Screening
25%
Drug Screening
25%
Animal Testing
25%
Toxicology Testing
25%